| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e74545f8a2da03a49850396c0578242f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0639
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001129
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0784 |
| filingDate |
2016-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e82e35a1d60bc72839b25b8525007b63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7841afa3fd06b7528d5e6d9ab1e81315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97b37d459064b81178fc401516ee9837
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_791336d2ecb5a869ea69449aace74378 |
| publicationDate |
2016-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016213764-A1 |
| titleOfInvention |
Composite tissue cancer vaccine |
| abstract |
Disclosed are composite cancer vaccines, in one embodiment generated through 3-dimensional bioprinting or through inoculation of roller cultures. The utilization of decellularized biological matrices such as placental tissue or subintestinal submucosal tissue is disclosed as a substrate for 3-dimensional tissue culture. In one embodiment tumor cells are assembled with monocytes and/or mesenchymal stem cells to represent in vivo existing tumors. The invention teaches means of generating off-the-shelf tumor vaccines containing antigenic properties similar to in vivo growing tumors, which cannot be currently replicated under existing 2-dimensional tumor culture means of generating cell lines |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112569207-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018195308-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114939129-A |
| priorityDate |
2015-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |